I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
Bleomycin sulfate is used as a glycopeptide antibiotic. It is capable of inducing oxidative cleavage of the DNA backbone, leading to apoptosis and also degrades RNA, and has been reported to display selectivity for RNA over DNA. Bleomycin acts as a sclerosing agent.
WB Shelley.; ED Shelley. Intralesional bleomycin sulfate therapy for warts: a novel bifurcated needle puncture technique. Arch Dermatol. 1991, 127,(2), 234-236.
M Amer.; N Diab.; A Ramadan.; A Galal. Therapeutic evaluation for intralesional injection of bleomycin sulfate in 143 resistant warts. Journal of the American Academy of Dermatology. 2015, 73,(4), 533-720.
Hazard Statements: H340-H351-H361d
May cause genetic defects. Suspected of causing cancer. Suspected of damaging the unborn child.
Precautionary Statements: P201-P202-P281-P308+P313-P501c
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Use personal protective equipment as required. IF exposed or concerned: Get medical advice/attention. Dispose of contents/ container to an approved waste disposal plant